Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2025-02-13 to 2025-02-13
Current total value of award: $1266.82
Description: 4567263807!XIFAXAN 200 MG TAB 30S